All Stories

  1. Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer’s Disease

    Article • Journal of Alzheimer s Disease, January 2024, IOS Press

    Dr Mitchell K Lai

  2. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration

    Article • Brain Pathology, October 2018, Wiley

    Dr Mitchell K Lai

  3. Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer’s Disease

    Article • Journal of Alzheimer s Disease, December 2017, IOS Press

    Dr Mitchell K Lai

  4. Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer’s Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load

    Article • Journal of Alzheimer s Disease, January 2017, IOS Press

    Dr Mitchell K Lai

  5. Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson’s Disease Dementia

    Article • Journal of Parkinson s Disease, October 2016, IOS Press

    Dr Mitchell K Lai

  6. An isoform-specific role of FynT tyrosine kinase in Alzheimer's disease

    Article • Journal of Neurochemistry, December 2015, Wiley

    Dr Mitchell K Lai

  7. Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer’s disease patients

    Article • Psychopharmacology, November 2015, Springer Science + Business Media

    Dr Mitchell K Lai

  8. Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias

    Article • Journal of the Neurological Sciences, April 2012, Elsevier

    Dr Mitchell K Lai

  9. Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease

    Article • Neurochemistry International, June 2011, Elsevier

    Dr Mitchell K Lai

  10. Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex

    Article • Neurochemistry International, December 2010, Elsevier

    Dr Mitchell K Lai

  11. Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer’s disease

    Article • Psychopharmacology, July 2010, Springer Science + Business Media

    Dr Mitchell K Lai

  12. Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease

    Article • Journal of Neuroscience Research, January 2009, Wiley

    Dr Mitchell K Lai

  13. Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease

    Article • Neurobiology of Aging, October 2008, Elsevier

    Dr Mitchell K Lai

  14. Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer’s disease neuropathology

    Article • Journal of Neural Transmission, May 2008, Springer Science + Business Media

    Dr Mitchell K Lai

  15. Loss of [3H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer’s disease patients with psychosis

    Article • Psychopharmacology, March 2008, Springer Science + Business Media

    Dr Mitchell K Lai

  16. Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease

    Article • Neurobiology of Aging, September 2007, Elsevier

    Dr Mitchell K Lai

  17. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease

    Article • Neurobiology of Aging, September 2006, Elsevier

    Dr Mitchell K Lai

  18. Selective effects of the APOE ε4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease

    Article • Neurobiology of Disease, June 2006, Elsevier

    Dr Mitchell K Lai

  19. Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer’s disease

    Article • Psychopharmacology, November 2004, Springer Science + Business Media

    Dr Mitchell K Lai

  20. Serotonin transporters are preserved in the neocortex of anxious Alzheimerʼs disease patients

    Article • Neuroreport, July 2003, Wolters Kluwer Health

    Dr Mitchell K Lai

  21. Serotonin transporters are preserved in the neocortex of anxious Alzheimer??s disease patients

    Article • Neuroreport, July 2003, Wolters Kluwer Health

    Dr Mitchell K Lai

  22. Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease

    Article • Brain Research, June 2003, Elsevier

    Dr Mitchell K Lai

  23. Postmortem serotoninergic correlates of cognitive decline in Alzheimer??s disease

    Article • Neuroreport, July 2002, Wolters Kluwer Health

    Dr Mitchell K Lai

  24. Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex

    Article • Neurology, September 2001, Wolters Kluwer Health

    Dr Mitchell K Lai